Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.11.011 ◽

2018 ◽

Vol 18 (2) ◽

pp. 106-113 ◽

Author(s):

Jan Vydra ◽

Cyril Šálek ◽

Jiří Schwarz ◽

Pavel Žák ◽

Jan Novák ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Myeloid Leukemia ◽

Intermediate Risk ◽

Real World Data ◽

Postremission Therapy ◽

First Complete Remission ◽

Download Full-text

Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015

Annals of Hematology ◽

10.1007/s00277-021-04670-1 ◽

2021 ◽

Author(s):

Hsin-An Hou ◽

Huey-En Tzeng ◽

Hung-Yi Liu ◽

Wen-Chien Chou ◽

Hwei-Fang Tien ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Survival Outcome ◽

Real World Data ◽

Download Full-text

Medical Cost Estimation for Elderly Acute Myeloid Leukemia (Aml) Using Real World Data in Japan

Value in Health ◽

10.1016/j.jval.2018.07.099 ◽

2018 ◽

Vol 21 ◽

pp. S13

Author(s):

K Kogushi ◽

K Nakamura ◽

S Ikeda

Keyword(s):

Acute Myeloid Leukemia ◽

Medical Cost ◽

Cost Estimation ◽

Myeloid Leukemia ◽

Real World Data ◽

Download Full-text

Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.796 ◽

2018 ◽

Vol 24 (4) ◽

pp. 779-788 ◽

Author(s):

Jia Chen ◽

Lingyi Yang ◽

Yi Fan ◽

Yang Xu ◽

Yue Han ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Intermediate Risk ◽

First Complete Remission ◽

Download Full-text

A Comparison of the Outcomes of Autologous and Unrelated-Donor Transplantation in Adult Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.11.298 ◽

2016 ◽

Vol 22 (3) ◽

pp. S30-S31 ◽

Author(s):

Motonori Mizutani ◽

Akiyoshi Takami ◽

Masahiko Hara ◽

Shohei Mizuno ◽

Masamitsu Yanada ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Myeloid Leukemia ◽

Unrelated Donor ◽

Intermediate Risk ◽

First Complete Remission ◽

Download Full-text

Faculty Opinions recommendation of Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160239.620540 ◽

2009 ◽

Author(s):

Parameswaran Hari

Keyword(s):

Acute Myeloid Leukemia ◽

Acute Leukemia ◽

Myeloid Leukemia ◽

Real World Data ◽

Download Full-text

Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission

Leukemia & Lymphoma ◽

10.3109/10428194.2015.1088646 ◽

2016 ◽

Vol 57 (7) ◽

pp. 1560-1566 ◽

Author(s):

Gabriel N. Mannis ◽

Thomas G. Martin ◽

Lloyd E. Damon ◽

Aaron C. Logan ◽

Rebecca L. Olin ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Myeloid Leukemia ◽

Cell Transplant ◽

Intermediate Risk ◽

Long Term Outcomes ◽

Hematopoietic Cell Transplant ◽

First Complete Remission ◽

Download Full-text

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype

International Journal of Hematology ◽

10.1007/s12185-010-0515-y ◽

2010 ◽

Vol 91 (3) ◽

pp. 436-445 ◽

Author(s):

Philipp G. Hemmati ◽

Theis H. Terwey ◽

Gero Massenkeil ◽

Philipp le Coutre ◽

Lam G. Vuong ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Intermediate Risk ◽

Reduced Intensity Conditioning ◽

First Complete Remission ◽

Reduced Intensity ◽

Download Full-text

Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.10.023 ◽

2014 ◽

Vol 20 (2) ◽

pp. 202-208 ◽

Author(s):

Erica D. Warlick ◽

Kristjan Paulson ◽

Ruta Brazauskas ◽

Xiaobo Zhong ◽

Alan M. Miller ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Myeloid Leukemia ◽

Allogeneic Transplantation ◽

Reduced Intensity Conditioning ◽

Postremission Therapy ◽

First Complete Remission ◽

Reduced Intensity ◽

Download Full-text

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies

PLoS ONE ◽

10.1371/journal.pone.0132620 ◽

2015 ◽

Vol 10 (7) ◽

pp. e0132620 ◽

Author(s):

Dandan Li ◽

Li Wang ◽

Honghu Zhu ◽

Liping Dou ◽

Daihong Liu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Complete Remission ◽

Myeloid Leukemia ◽

Meta Analysis ◽

Intermediate Risk ◽

Hematopoietic Stem ◽

First Complete Remission ◽

Download Full-text

PCN285 USE OF REAL-WORLD DATA AND MACHINE LEARNING TO REDUCE TREATMENT-LIMITING ADVERSE EVENTS IN AN ACUTE MYELOID LEUKEMIA CLINICAL TRIAL POPULATION

Value in Health ◽

10.1016/j.jval.2020.04.1751 ◽

2020 ◽

Vol 23 ◽

pp. S74

Author(s):

R. Buderi ◽

J. Ransom ◽

A. Galaznik ◽

M. Berger

Keyword(s):

Machine Learning ◽

Clinical Trial ◽

Acute Myeloid Leukemia ◽

Adverse Events ◽

Myeloid Leukemia ◽

Real World Data ◽

Download Full-text